Sleeping Pills

Sleeping Pills Market Outlook

The global sleeping pills market was valued at approximately USD 6.1 billion in 2023 and is projected to reach around USD 9.2 billion by 2035, growing at a robust CAGR of 6.5% over the forecast period. The increasing prevalence of sleep-related disorders, fueled by lifestyle changes and rising stress levels, is a significant factor driving this growth. Moreover, the growing awareness about the importance of sleep health has led to an uptick in the consumption of sleeping aids. The rise in mental health issues, particularly anxiety and depression, has also contributed to the expansion of this market. Additionally, the shift towards self-medication and the availability of a variety of sleeping pills, including herbal and over-the-counter options, have made these products more accessible to consumers.

Growth Factor of the Market

Several factors are contributing to the growth of the sleeping pills market, particularly the burgeoning prevalence of insomnia and other sleep disorders among diverse demographics. The modern lifestyle, characterized by high levels of stress, irregular sleep patterns, and increased screen time, has significantly impacted sleep quality, thereby increasing reliance on sleeping medications. In addition, the rise in aging populations globally has resulted in a higher incidence of sleep disorders, further propelling the demand for sleeping pills. Furthermore, advancements in drug formulations and the introduction of novel therapies for sleep management have created lucrative opportunities for market players. The growing trend of e-commerce in the pharmaceutical sector has also facilitated easier access to a wide range of sleeping aids, further boosting market growth.

Key Highlights of the Market

• The market is expected to grow at a CAGR of 6.5% from 2025 to 2035.
• Prescription sleeping pills hold a significant market share, driven by healthcare provider recommendations.
• Insomnia remains the primary application area for sleeping pills, with a growing focus on chronic sleep disorders.
• North America is the largest market region, accounting for approximately 40% of the global market share.
• The trend towards self-medication is leading to increased sales of over-the-counter sleeping pills.

By Product Type

Prescription Sleeping Pills:

Prescription sleeping pills form a substantial segment of the sleeping pills market, primarily due to their effectiveness in treating severe insomnia and other sleep disorders. These medications are typically prescribed by healthcare providers after a thorough evaluation of a patient's sleep patterns and potential underlying issues. Drugs such as benzodiazepines and non-benzodiazepine medications are included in this category, which are known to induce sleep quickly and improve sleep quality. However, the prescription nature of these pills can limit their availability and increase the risk of dependency, making healthcare providers cautious about their long-term use.

Over-the-Counter Sleeping Pills:

Over-the-counter (OTC) sleeping pills have seen significant growth in popularity due to their ease of access and perceived safety compared to prescription alternatives. These medications often contain antihistamines or natural ingredients and are marketed for mild insomnia or occasional sleeplessness. The self-medication trend has propelled the sales of OTC sleeping aids, as consumers can easily purchase them without a prescription. However, there is a growing awareness regarding the potential side effects and the importance of consulting healthcare professionals before using these medications regularly.

Herbal Sleeping Pills:

Herbal sleeping pills have gained traction in recent years as consumers increasingly seek natural alternatives to chemically formulated medications. Ingredients such as valerian root, chamomile, and passionflower are commonly used in these supplements. The appeal of herbal sleeping pills lies in their perceived safety profile and fewer side effects compared to traditional pharmaceutical options. As more individuals become health-conscious and prefer holistic approaches to wellness, the market for herbal sleeping aids is expected to expand further, catering to a demographic that prioritizes natural solutions for sleep issues.

Melatonin Supplements:

Melatonin supplements represent a growing segment within the sleeping pills market, primarily due to their role in regulating the sleep-wake cycle. Melatonin is a hormone naturally produced by the body, and its supplementation is widely used for managing sleep disorders, particularly in cases related to jet lag or shift work. These supplements are often regarded as safe and effective, contributing to their popularity among consumers looking for non-prescription solutions to enhance their sleep quality. Increased awareness around the importance of circadian rhythms and sleep health has driven the demand for melatonin supplements, making them a preferred choice among various age groups.

Others:

The 'Others' category within the product type segment includes various unconventional sleep aids and experimental therapies that are emerging in the market. These may consist of products incorporating non-traditional ingredients, combinations of various herbal extracts, and even digital wellness technologies designed to promote better sleep hygiene. As the market evolves, there is a growing interest in exploring alternative solutions beyond conventional medications, driven by a broader understanding of sleep health and wellness. This segment's growth reflects the ongoing innovation in product offerings aimed at enhancing sleep quality.

By Application

Insomnia:

Insomnia is the most prominent application for sleeping pills, accounting for a significant portion of the market. Insomnia can manifest as difficulty falling asleep, staying asleep, or waking up too early, and it has become increasingly prevalent in today's fast-paced world. The rising awareness of sleep disorders and their impact on overall health has led to a growing demand for effective treatment options. Sleeping pills prescribed for insomnia range from short-acting to long-acting agents, catering to varying degrees of sleep difficulties experienced by patients. As more individuals seek solutions for chronic insomnia, this application segment is expected to witness substantial growth in the coming years.

Sleep Disorders:

Other sleep disorders, which include conditions such as sleep apnea, restless leg syndrome, and narcolepsy, also drive the demand for sleeping pills. These disorders can significantly affect an individual's quality of life, leading to daytime fatigue, cognitive impairment, and other health issues. The variety of medications available to address different sleep disorders ensures that patients receive tailored solutions according to their specific needs. As more healthcare providers identify and treat sleep disorders, the segment dedicated to these applications is anticipated to expand, supported by growing research on sleep-related health issues.

Anxiety:

Anxiety is increasingly recognized as a significant contributor to sleep disturbances, prompting a rise in the use of sleeping pills among individuals experiencing heightened stress levels. The intersection between mental health and sleep health has gained attention, with many sleep medications being prescribed to alleviate anxiety symptoms as well as promote restful sleep. It is not uncommon for healthcare providers to recommend sleeping pills as part of a comprehensive treatment plan for anxiety disorders, leading to increased consumption in this application segment. The ongoing dialogue surrounding mental health and its impact on sleep will likely continue to fuel growth in the market.

Depression:

Depression is another critical application area for sleeping pills, as individuals suffering from depressive disorders often experience sleep disturbances. The relationship between sleep and mental health is complex, with poor sleep exacerbating depressive symptoms and vice versa. Many antidepressant medications also have sedative properties, further linking the treatment of depression with sleep aids. As mental health awareness grows and individuals seek comprehensive care for their conditions, the market for sleeping pills prescribed for depression is expected to grow, leading to increased healthcare interventions focusing on sleep health.

Others:

The 'Others' category within the application segment encompasses various less common reasons for using sleeping pills, including lifestyle changes, travel-related sleep disruptions, and certain medical conditions that affect sleep patterns. This segment is characterized by a diverse population of users who may not fall into the more conventional categories of insomnia or anxiety-related sleep issues. The continued evolution of lifestyle factors, such as shift work, increased screen time, and an aging population, contributes to the demand for sleeping pills in this category. As awareness of sleep health improves, this application segment is poised to expand as more individuals seek solutions tailored to specific circumstances affecting their sleep.

By Distribution Channel

Pharmacies:

Pharmacies are one of the key distribution channels for sleeping pills, accounting for a sizeable share of the market. Traditional brick-and-mortar pharmacies offer consumers access to a wide range of sleeping aids, including both prescription and over-the-counter options. The presence of pharmacists allows consumers to receive personalized advice regarding the appropriate selection of sleeping pills based on their individual needs. This face-to-face interaction fosters trust and provides an essential service for those seeking guidance on managing sleep-related issues. The pharmacy channel is expected to continue its dominance as a reliable source for accessing sleep medications.

Online Pharmacies:

The rise of e-commerce has significantly impacted the sleeping pills market, with online pharmacies becoming an increasingly popular distribution channel. The convenience of purchasing medications from the comfort of one's home has led to a surge in sales through this channel. Online pharmacies often provide competitive pricing and a broader selection of products than traditional pharmacies, appealing to a tech-savvy consumer base. Furthermore, the anonymity associated with online purchasing can encourage individuals to seek help for sleep issues that they may otherwise hesitate to discuss in person. The online pharmacy segment is projected to grow rapidly as more consumers embrace digital solutions in health and wellness.

Drug Stores:

Drug stores have also established themselves as a significant distribution channel for sleeping pills, catering to both prescription and OTC products. These stores often serve local communities and provide a convenient shopping option for consumers seeking quick access to sleep aids. The visibility of sleeping pills on drug store shelves facilitates impulse buying while providing consumers with a variety of options to choose from. With the ongoing trend toward self-medication, drug stores can capitalize on the demand for readily available sleeping aids, bolstering their position in the market.

Hospitals:

Hospitals play a crucial role in the distribution of sleeping pills, particularly for patients undergoing treatment for sleep disorders, mental health conditions, or undergoing surgical procedures that may disrupt their sleep. In-hospital pharmacies ensure that patients have access to necessary medications during their stay. Healthcare providers can closely monitor the administration of sleeping medications in such settings, providing tailored treatment plans for each patient based on their individual needs. The hospital distribution channel is vital for ensuring that patients receive appropriate care, particularly for those who require immediate interventions for sleep-related issues.

Others:

The 'Others' category in the distribution channel segment includes alternative retail outlets and direct-to-consumer sales approaches, such as wellness shops, health food stores, and subscription-based services. These channels cater to a niche market of consumers seeking alternative and natural sleeping aids. The emergence of holistic health trends has led to increased interest in unconventional retail options, where consumers can find herbal supplements, melatonin products, and other natural solutions for sleep. As the market diversifies and consumer preferences shift, these alternative distribution channels are likely to see continued growth.

By Ingredient Type

Diphenhydramine:

Diphenhydramine is an antihistamine commonly used as an active ingredient in various over-the-counter sleeping pills. It works by blocking histamine receptors in the brain, leading to drowsiness and promoting sleep. Diphenhydramine is often used for short-term sleep issues, making it a popular choice for individuals who occasionally experience sleeplessness. This ingredient's availability in numerous OTC products has contributed to its widespread use, although potential side effects such as morning grogginess and dry mouth have raised concerns regarding long-term use. As awareness of its efficacy and side effects grows, the market for diphenhydramine-based sleeping pills remains strong.

Doxylamine:

Doxylamine is another antihistamine frequently used in the formulation of sleeping pills, particularly in combination with other active ingredients. Like diphenhydramine, doxylamine induces drowsiness and is commonly found in OTC sleep aids. Its effectiveness for short-term insomnia has made it a favored choice among consumers seeking relief from occasional sleeplessness. Doxylamine is known for its relatively short onset of action, allowing users to fall asleep quickly. While generally considered safe for short-term use, its side effects and potential for dependency are factors consumers must consider when opting for doxylamine-containing products.

Valerian Root:

Valerian root is recognized for its natural sedative properties and is commonly used in herbal sleeping pills as a non-pharmaceutical alternative for promoting sleep. Valerian root has been utilized for centuries in traditional medicine and has gained popularity among consumers seeking natural solutions for insomnia and anxiety-related sleep disturbances. Its gentle activity and lack of severe side effects differentiate it from traditional sleeping pills, making it an appealing option for those wary of pharmacological treatments. The growing trend towards holistic health and wellness is driving the demand for valerian root-based formulations in the market.

Melatonin:

Melatonin is a hormone naturally produced by the body that regulates the sleep-wake cycle, making it a commonly used ingredient in sleeping pills, particularly for addressing circadian rhythm-related sleep issues. Melatonin supplements have gained prominence as a non-habit-forming sleep aid and are popular among individuals dealing with jet lag or irregular sleep patterns. The ingredient's safety profile and perceived lack of serious side effects have contributed to its widespread acceptance among consumers. With increased awareness of the importance of sleep health, the market for melatonin-based sleeping aids is anticipated to continue expanding as more people seek natural alternatives to traditional medications.

Others:

The 'Others' category within the ingredient type segment comprises various alternative ingredients used in different formulations of sleeping pills. This may include herbal extracts, amino acids, and other natural compounds that are believed to aid in sleep promotion. As consumer interest in natural remedies grows, these alternative ingredients are becoming more common in the market, catering to a demographic that prioritizes holistic health approaches. The diversity of ingredient types reflects the ongoing innovation in the sleep aid market, with new formulations continually emerging to meet consumer demands for effective and safe solutions for sleep-related issues.

By Region

The North American region currently dominates the sleeping pills market, accounting for approximately 40% of the global share. The growing prevalence of sleep disorders, coupled with increased awareness regarding sleep health, has fueled demand for both prescription and over-the-counter sleeping aids. In North America, consumers have greater access to a wide range of products, including herbal and natural remedies, leading to a growing trend towards self-medication. Moreover, the increase in mental health issues and related sleep disturbances has significantly contributed to the market's expansion in this region. The North American sleeping pills market is expected to grow at a CAGR of 6.2% over the forecast period, driven by the continued focus on sleep health and wellness.

Europe is the second-largest market for sleeping pills, holding a significant share of the global landscape. Countries such as Germany, the United Kingdom, and France exhibit high consumption rates of sleeping aids due to the increasing prevalence of sleep disorders, particularly insomnia and anxiety-related conditions. In Europe, there is also a growing emphasis on natural and herbal sleeping aids, which is influencing consumer choices and market dynamics. The region is expected to experience a steady growth rate, with a projected CAGR of approximately 6.0% from 2025 to 2035. Factors such as rising healthcare expenditure and growing awareness of mental health issues are anticipated to propel the market further in this region.

Opportunities

The sleeping pills market presents numerous opportunities for growth, especially as consumer preferences shift towards natural and organic solutions for sleep-related issues. The increasing demand for herbal and melatonin-based products reflects a broader trend toward holistic health and wellness, offering significant potential for companies that innovate and diversify their product offerings. Additionally, advancements in technology, such as sleep-tracking devices and mobile applications focused on sleep management, present opportunities for collaboration and product integration within the sleeping pills market. Firms that can leverage these trends and develop comprehensive solutions for sleep health may find themselves positioned favorably in the evolving landscape.

Moreover, the growing focus on mental health and its connection to sleep quality presents further avenues for market expansion. As more individuals recognize the importance of addressing both mental and physical health to achieve optimal sleep, the demand for sleeping pills tailored to specific conditions like anxiety and depression is likely to increase. Research and development efforts aimed at creating innovative formulations with fewer side effects or improved efficacy will also be critical in capturing market share. The increasing engagement of healthcare professionals in advocating for sleep health solutions is likely to bolster the market, providing opportunities for companies to establish partnerships and enhance their visibility.

Threats

Despite the growth potential of the sleeping pills market, several threats could hinder progress. One significant challenge is the increasing awareness regarding the risks associated with long-term use of prescription and over-the-counter sleeping medications, including dependency and withdrawal symptoms. As consumers become more informed about the potential side effects, there may be a shift towards alternative solutions, resulting in reduced sales for traditional sleeping aids. Furthermore, regulatory scrutiny surrounding the marketing and promotion of sleep medications has intensified, possibly leading to stricter guidelines and limitations on product claims, which could negatively impact market growth.

Additionally, the rise of alternative therapies and lifestyle changes that promote better sleep, such as cognitive behavioral therapy (CBT), meditation, and sleep hygiene practices, poses a threat to the traditional sleeping pills market. As more individuals seek non-pharmaceutical interventions to manage their sleep issues, the demand for conventional sleeping aids could decrease. The competition from these alternative approaches may force manufacturers to innovate or diversify their product offerings to maintain market relevance and prevent potential losses in market share.

Competitor Outlook

• Pfizer Inc.
• Sanofi S.A.
• Teva Pharmaceutical Industries Ltd.
• Eli Lilly and Company
• Merck & Co., Inc.
• Novartis AG
• GlaxoSmithKline Plc
• Johnson & Johnson
• AbbVie Inc.
• Restoril (Temazepam) by Valeant Pharmaceuticals
• SleepWell (Melatonin) by Natrol, LLC
• Pure Sleep (Valerian) by Herbalife Nutrition Ltd.
• ZzzQuil by Procter & Gamble
• Nature's Way (Valerian Root) by Nature's Way Products, LLC
• Somnapure by Pure Sleep

The competitive landscape in the sleeping pills market is marked by a mix of established pharmaceutical giants and emerging companies specializing in natural and herbal sleeping aids. Key players such as Pfizer, Sanofi, and Merck dominate the prescription segment of the market, offering a variety of medications for sleep disorders, each with unique mechanisms of action and benefits. These companies leverage extensive research and development capabilities to bring innovative products to market while adhering to strict regulatory requirements. The introduction of generic alternatives has further intensified competition, as cost-effective options provide consumers with a broader range of choices. Consequently, larger firms must continuously innovate to maintain a competitive edge and respond to changing consumer preferences.

Simultaneously, the increasing popularity of natural and herbal sleep aids has led to the emergence of niche players in the market. Companies like Natrol, Herbalife, and Nature's Way focus on developing products that align with the growing consumer trend toward holistic wellness and self-care. These organizations emphasize the use of high-quality, natural ingredients in their formulations, appealing to health-conscious consumers seeking alternatives to traditional pharmaceuticals. The competition among these emerging companies is expected to intensify as they strive to capture market share and establish brand loyalty within a rapidly evolving landscape. Collaborations, partnerships, and acquisitions are likely strategies employed by both established and emerging players to enhance product offerings and expand distribution channels.

Among the major companies, Pfizer Inc. stands out with its widely prescribed sleeping pill, Lunesta (Eszopiclone), known for its efficacy in treating insomnia. Sanofi S.A. offers Ambien (Zolpidem), another popular medication for sleep problems, which has a strong market presence due to its effectiveness and brand recognition. In the natural segment, companies like Natrol, LLC have carved out a niche by providing melatonin and valerian root supplements that align with growing consumer interest in natural remedies. As the market continues to evolve, these companies will need to adapt to changing consumer behaviors, regulatory landscapes, and emerging competitive threats to sustain their positions in the market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 AbbVie Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Novartis AG
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Pfizer Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Sanofi S.A.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Johnson & Johnson
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Merck & Co., Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 GlaxoSmithKline Plc
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Eli Lilly and Company
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Somnapure by Pure Sleep
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 ZzzQuil by Procter & Gamble
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Teva Pharmaceutical Industries Ltd.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 SleepWell (Melatonin) by Natrol, LLC
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Restoril (Temazepam) by Valeant Pharmaceuticals
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Pure Sleep (Valerian) by Herbalife Nutrition Ltd.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Nature's Way (Valerian Root) by Nature's Way Products, LLC
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Sleeping Pills Market, By Application
    • 6.1.1 Insomnia
    • 6.1.2 Sleep Disorders
    • 6.1.3 Anxiety
    • 6.1.4 Depression
    • 6.1.5 Others
  • 6.2 Sleeping Pills Market, By Product Type
    • 6.2.1 Prescription Sleeping Pills
    • 6.2.2 Over-the-Counter Sleeping Pills
    • 6.2.3 Herbal Sleeping Pills
    • 6.2.4 Melatonin Supplements
    • 6.2.5 Others
  • 6.3 Sleeping Pills Market, By Ingredient Type
    • 6.3.1 Diphenhydramine
    • 6.3.2 Doxylamine
    • 6.3.3 Valerian Root
    • 6.3.4 Melatonin
    • 6.3.5 Others
  • 6.4 Sleeping Pills Market, By Distribution Channel
    • 6.4.1 Pharmacies
    • 6.4.2 Online Pharmacies
    • 6.4.3 Drug Stores
    • 6.4.4 Hospitals
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Sleeping Pills Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Sleeping Pills market is categorized based on

By Product Type

• Prescription Sleeping Pills
• Over-the-Counter Sleeping Pills
• Herbal Sleeping Pills
• Melatonin Supplements
• Others

By Application

• Insomnia
• Sleep Disorders
• Anxiety
• Depression
• Others

By Distribution Channel

• Pharmacies
• Online Pharmacies
• Drug Stores
• Hospitals
• Others

By Ingredient Type

• Diphenhydramine
• Doxylamine
• Valerian Root
• Melatonin
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Pfizer Inc.
• Sanofi S.A.
• Teva Pharmaceutical Industries Ltd.
• Eli Lilly and Company
• Merck & Co., Inc.
• Novartis AG
• GlaxoSmithKline Plc
• Johnson & Johnson
• AbbVie Inc.
• Restoril (Temazepam) by Valeant Pharmaceuticals
• SleepWell (Melatonin) by Natrol, LLC
• Pure Sleep (Valerian) by Herbalife Nutrition Ltd.
• ZzzQuil by Procter & Gamble
• Nature's Way (Valerian Root) by Nature's Way Products, LLC
• Somnapure by Pure Sleep